Status:

NOT_YET_RECRUITING

Evaluation of the Diagnostic Performance of the TestNPass DM-DIV for SARS-CoV-2 Using a Nasopharyngeal Sample

Lead Sponsor:

University Hospital, Grenoble

Conditions:

SARS-CoV-2 Infection

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The COVID-19 pandemic has created a major global health crisis that requires a rapid and effective response, particularly in the field of diagnostics. The first tests used, based on PCR (polymerase c...

Detailed Description

The COVID-19 pandemic and the global spread of SARS-CoV-2 are historic events in terms of their magnitude and the collective response they have elicited from medical teams, governments and the general...

Eligibility Criteria

Inclusion

  • Adults ≥18 years of age
  • Consulting or hospitalized at the University Hospital of Grenoble Alpes, for whom a SARS-CoV-2 RT-PCR test via nasal swab is considered due to symptoms or context (hospitalization in a double room, ongoing epidemic outbreak)
  • Having provided informed consent to participate in the study.
  • Patient having the rights to French social insurance

Exclusion

  • Contraindication to nasopharyngeal swabbing:
  • Anatomical abnormalities or medical conditions:
  • Severe nasal septum deviation or nasal polyps
  • History of recent nasal or facial surgery
  • Severe sinusitis or nasal infections
  • Bleeding disorders
  • Extreme sensitivity or phobias related to medical procedures
  • Participation in an exclusion period of another SARS-CoV-2 performance study: Minors
  • Pregnant or breastfeeding women, Individuals under guardianship or curatorship, Individuals deprived of liberty or involuntarily hospitalized, Individuals under administrative or judicial supervision, Persons unable to provide informed consent
  • Staff with a hierarchical relationship with the principal investigator

Key Trial Info

Start Date :

April 30 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2025

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT06917261

Start Date

April 30 2025

End Date

December 30 2025

Last Update

April 8 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University Hospital of Grenoble, emergency department

Grenoble, France, 38700

2

University Hospital of Grenoble, infectious disease department

Grenoble, France, 38700